BannerBio, a world leader in the analysis, identification, production and processing of bioactive ingredients derived from plants, supplies its terminal manufacturers with superior premix.

Since its inception just over 10 years ago, Bannerbio which was established by the collaborative effort of several people has now grown into a thriving company with two research centers, three manufacturing plants and has established its own plantation base and stable raw material suppliers in Europe and Africa. It has set up a network of distribution centers which include North America as well.

The research center which focuses on the identification, extraction, processing and formulation of botanical bioactive ingredients was established in Shenzhen, China. In keeping with its long-standing tradition, Bannerbio has replaced the high energy-consuming processes and has, instead substituted them for more energy-efficient methods by using unique high activity technology in the production process. Bannerbio maintains the most-up-to-date energy-efficient processes by applying the new technology continuously through National and International collaboration with Universities and Research Institutes since its establishment.

The complex process of developing botanical bioactive ingredients into products by Bannerbio, not only involves the identification, isolation, and formulation of a certain ingredient, but also the expenditure of tremendous effort by its own R&D team and its collaborators from University and Institute research centers to study its mechanism(s) to further advance discovery of new applications For example, as a result of more in depth investigation of the natural botanical product Grape Seed Extract produced by Bannererbio, preliminary findings suggest that it may reduce the incidence and severity of Alzheimer's disease by its ability to reduce the levels of Tau protein associated with increased amyloidosis in the central nervous system,

Bannerbio has a long history of pursuing the R&D component that creates an environment of innovation for the development bioactive ingredients as evidenced by the several patents obtained each year.

For many years, the various international enterprises have always occupied a leading position in the formulation, development, application and most importantly, the commercialization of their bioactive ingredients. In China, plant extract manufacturer basically only provided the raw materials for the industry. Despite having an extensive research effort on their own botanical extract, these Chinese-based companied seldom further developed these final products to the point of establishing their highly commercializable health-promoting applications which are the most crucial segment in closely connecting the significance and uniqueness of the botanical extract with the downstream purchaser.

A key strategy that will allow BannerBio to obtain considerable advantage in the development and commercialization of its unique bioactive ingredients is its long-standing and continued effort to establish cooperative research agreements with select well-known Universities and Institutes from the USA. An immediate result of such collaboration was the creation of Bannerbio's unique microencapsulation technology referred to as "NanoEncaps® " which will provide both national and international terminal manufacturers with a bioactive ingredient formulation which overcomes the traditional problems instability, insolubility, reduced fluidity and bioavailability, all associated with decreased efficacy.